Contractor
MYLAN PHARMACEUTICALS INC
MORGANTOWN, WV
- UEI
- NDN1MYB8DKK5
- Parent UEI
- TZY5BKQHCF21
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$01
Awards
2
Agencies served
1
Active from Nov 25, 2022 to Aug 3, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36F79723D0025 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | Nov 25, 2022 | — |
| 36E79726D0033 2 LINE ITEMS FOR BUDESONIDE/FORMOTEROL ORAL INHALERS. AWARDED FOR A BASE YEAR OF 8/7/2026 TO 8/6/2027 PLUS 4 ONE-YEAR PERIODS. | Department of Veterans Affairs | — | Jul 24, 2026 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier NDN1MYB8DKK5, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.